Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05132868 | Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling | completed | N/A | 78 | Stanford UniversityOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT03190265 | Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer | completed | Phase 2 | 61 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 7, 2024 | clinicaltrials |
| NCT05496777 | Home-based Prehabilitation in Pancreatic Resection | completed | N/A | 45 | Nicole HildebrandOTHER | 2 | Aug 5, 2024 | clinicaltrials |
| NCT02697058 | Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer | completed | Phase 2 | 84 | Institut de Recherches Internationales ServierOTHER | 1 | Jul 25, 2024 | clinicaltrials |
| NCT03819387 | A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer | completed | Phase 1 | 49 | Nitto BioPharma, Inc.INDUSTRY | 1 | Jul 24, 2024 | clinicaltrials |
| NCT03336216 | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 205 | Bristol-Myers SquibbINDUSTRY | 11 | Jul 23, 2024 | clinicaltrials |
| NCT01231347 | QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas(GAMMA) | completed | Phase 3 | 800 | NantCell, Inc.INDUSTRY | 32 | Jul 16, 2024 | clinicaltrials |
| NCT02352337 | First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem(PANOPTIMOX) | completed | Phase 2 | 276 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT02827201 | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine(FIRGEMAX) | completed | Phase 2 | 127 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT03752398 | A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)(DUET-3) | completed | Phase 1 | 198 | Xencor, Inc.INDUSTRY | 1 | Jul 5, 2024 | clinicaltrials |
| NCT03077685 | Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma | completed | Phase 2 | 54 | NanOlogy, LLCINDUSTRY | 1 | Jun 24, 2024 | clinicaltrials |
| NCT05518071 | FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1(FLUOPANC) | completed | Phase 2 | 20 | Leiden University Medical CenterOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06068452 | Role of Pre-operative CPET in Pancreatoduodenectomy(WHIPPLES) | completed | — | 113 | East Lancashire Hospitals NHS TrustOTHER | 1 | Jun 18, 2024 | clinicaltrials |
| NCT06461598 | Signature for Precise Chemosensitivity Prediction in PDAC | completed | — | 365 | Ruijin HospitalOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT03813368 | Whipples Resection in Octogenarians | completed | — | 500 | University of EdinburghOTHER | 1 | Jun 13, 2024 | clinicaltrials |
| NCT05514171 | Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline(PaNLoCat) | completed | — | 300 | Hospital del MarOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT01580397 | Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer | completed | Phase 2 | 15 | ImmunityBio, Inc.INDUSTRY | 1 | Jun 6, 2024 | clinicaltrials |
| NCT06079229 | Quality of Life in Elderly Patients After Pancreatic Cancer Surgery(ADL_DPC_PA) | completed | — | 12 | Hospices Civils de LyonOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT04400383 | Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors | completed | Phase 1 | 62 | CARsgen Therapeutics Co., Ltd.INDUSTRY | 1 | May 24, 2024 | clinicaltrials |
| NCT04604158 | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | completed | N/A | 38 | Gillian GreshamOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT03146962 | High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies | completed | Phase 2 | 61 | Weill Medical College of Cornell UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT01447732 | Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors | completed | Phase 1 | 71 | Kyowa Kirin Co., Ltd.INDUSTRY | 0 | Apr 29, 2024 | clinicaltrials |
| NCT03307564 | Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer | completed | N/A | 6 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT04002128 | Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery | completed | N/A | 120 | Osijek University HospitalOTHER | 0 | Apr 23, 2024 | clinicaltrials |
| NCT06378853 | Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients | completed | — | 548 | Jinling Hospital, ChinaOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06378580 | The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma | completed | — | 72 | Luo CongOTHER | 1 | Apr 22, 2024 | clinicaltrials |
| NCT01931644 | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | completed | — | 17,667 | Sanguine BiosciencesINDUSTRY | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04595058 | LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent(BAMPI) | completed | N/A | 123 | Hospital Universitari de BellvitgeOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT06363084 | A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer | completed | — | 64 | Ruijin HospitalOTHER | 0 | Apr 12, 2024 | clinicaltrials |
| NCT01827553 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy(CONKO-007) | completed | Phase 3 | 830 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT05191498 | Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer(SLOTH-1) | completed | N/A | 3 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT03490669 | Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors | completed | Phase 1 | 41 | AstraZenecaINDUSTRY | 3 | Apr 5, 2024 | clinicaltrials |
| NCT02395016 | A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer | completed | Phase 3 | 90 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT04181645 | SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer | completed | N/A | 40 | RenJi HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05476978 | Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions | completed | — | 130 | Huazhong University of Science and TechnologyOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT01761240 | Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC | completed | Phase 1 | 27 | MorphotekINDUSTRY | 1 | Mar 29, 2024 | clinicaltrials |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | completed | Phase 1 | 132 | Celldex TherapeuticsINDUSTRY | 1 | Mar 28, 2024 | clinicaltrials |
| NCT03373188 | VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer | completed | Phase 1 | 10 | Emory UniversityOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06316908 | Permanent Celiac Plexus Block: Comparison of Pain Score in Unilateral and Bilateral Posterior Percutaneous Approach | completed | Phase 4 | 30 | Sindh Institute of Urology and TransplantationOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT04431258 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study(PanC-ASAP) | completed | Phase 1 / Phase 2 | 150 | Ability Pharmaceuticals SLINDUSTRY | 4 | Mar 18, 2024 | clinicaltrials |
| NCT04119362 | PARAGON Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer(PARAGON) | completed | — | 469 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT04617067 | Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer | completed | Phase 2 | 15 | Cancer Trials IrelandNETWORK | 1 | Mar 6, 2024 | clinicaltrials |
| NCT00019006 | Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06278493 | A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 34 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04177810 | Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer | completed | Phase 2 | 25 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05161013 | A Proof-of-Concept Study Evaluating LINFU™ | completed | N/A | 12 | Adenocyte, LLCINDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06254430 | Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery | completed | — | 65 | Ankara City Hospital BilkentOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06267690 | A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC | completed | — | 295 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 9, 2024source: clinicaltrials